These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20202307)

  • 1. Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India.
    Michael JS; Daley P; Kalaiselvan S; Latha A; Vijayakumar J; Mathai D; John KR; Pai M
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):482-8. PubMed ID: 20202307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.
    Lora MH; Reimer-McAtee MJ; Gilman RH; Lozano D; Saravia R; Pajuelo M; Bern C; Castro R; Espinoza M; Vallejo M; Solano M; Challapa R; Torrico F
    BMC Infect Dis; 2015 Jun; 15():222. PubMed ID: 26047953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and low-cost microscopic observation drug susceptibility assay for detecting TB and MDR-TB among individuals infected by HIV in South India.
    Solomon S; Balakrishnan P; Vignesh R; Waldrop G; Solomon SS; Murugavel KG; Kumarasamy N; Yepthomi T; Poongulali S; Swathirajan CR; Sreenivasan V; Chandrasekar C; Suriakumar J; Mahilmaran A; Manoharan G; Moore DA
    Indian J Med Microbiol; 2013; 31(2):130-7. PubMed ID: 23867668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
    Arias M; Mello FC; Pavón A; Marsico AG; Alvarado-Gálvez C; Rosales S; Pessôa CL; Pérez M; Andrade MK; Kritski AL; Fonseca LS; Chaisson RE; Kimerling ME; Dorman SE
    Clin Infect Dis; 2007 Mar; 44(5):674-80. PubMed ID: 17278058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic-observation drug-susceptibility assay for the diagnosis of TB.
    Moore DA; Evans CA; Gilman RH; Caviedes L; Coronel J; Vivar A; Sanchez E; Piñedo Y; Saravia JC; Salazar C; Oberhelman R; Hollm-Delgado MG; LaChira D; Escombe AR; Friedland JS
    N Engl J Med; 2006 Oct; 355(15):1539-50. PubMed ID: 17035648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.
    Reddy KP; Brady MF; Gilman RH; Coronel J; Navincopa M; Ticona E; Chavez G; Sánchez E; Rojas C; Solari L; Valencia J; Pinedo Y; Benites C; Friedland JS; Moore DA
    Clin Infect Dis; 2010 Apr; 50(7):988-96. PubMed ID: 20192727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria.
    Ochang EA; Oduyebo OO; Onwuezobe IA; Collier D; Bode-Sojobi I; Odo M
    Niger J Med; 2016; 25(3):226-33. PubMed ID: 30011167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcolony culture techniques for tuberculosis diagnosis: a systematic review.
    Leung E; Minion J; Benedetti A; Pai M; Menzies D
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):16-23, i-iii. PubMed ID: 21986554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
    Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
    BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the microscopic observation drug susceptibility assay for four first-line drugs using Mycobacterium tuberculosis reference strains and clinical isolates.
    Nishiyama H; Aono A; Sugamoto T; Mizuno K; Chikamatsu K; Yamada H; Mitarai S
    J Microbiol Methods; 2014 Jun; 101():44-8. PubMed ID: 24717372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
    Lazarus RP; Kalaiselvan S; John KR; Michael JS
    Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings.
    Wang L; Mohammad SH; Chaiyasirinroje B; Li Q; Rienthong S; Rienthong D; Nedsuwan S; Mahasirimongkol S; Yasui Y
    J Clin Microbiol; 2015 Jan; 53(1):172-8. PubMed ID: 25378569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic observation drug-susceptibility assay vs. Xpert
    Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
    Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
    Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
    J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis.
    Minion J; Leung E; Menzies D; Pai M
    Lancet Infect Dis; 2010 Oct; 10(10):688-98. PubMed ID: 20813587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.
    Moore DA; Mendoza D; Gilman RH; Evans CA; Hollm Delgado MG; Guerra J; Caviedes L; Vargas D; Ticona E; Ortiz J; Soto G; Serpa J;
    J Clin Microbiol; 2004 Oct; 42(10):4432-7. PubMed ID: 15472289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay.
    Ha DT; Lan NT; Kiet VS; Wolbers M; Hang HT; Day J; Hien NQ; Tien NA; An PT; Anh TT; Oanh do TT; Hoa CL; Chau NT; Hai NN; Binh NT; Ngoc le H; Phuong DT; Quyet TV; Tuyen NT; Ha VT; Nho NT; Hoa DV; Anh PT; Dung NH; Farrar J; Caws M
    J Clin Microbiol; 2010 Dec; 48(12):4573-9. PubMed ID: 20926704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.
    Moore DA; Caviedes L; Gilman RH; Coronel J; Arenas F; LaChira D; Salazar C; Carlos Saravia J; Oberhelman RA; Hollm-Delgado MG; Escombe AR; Evans CA; Friedland JS
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):35-43. PubMed ID: 16678991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.